| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 09/25/2003 | CA2479676A1 Dexanabinol and dexanabinol analogs regulate inflammation related genes |
| 09/24/2003 | EP1345930A2 Pharmaceutical compounds |
| 09/24/2003 | EP1051412B1 Methods for separating a tocotrienol from a tocol-containing mixture and compositions thereof |
| 09/24/2003 | CN1122021C Amino acid derivatives and their use as pesticides |
| 09/24/2003 | CN1121857C Use of gamma RAR specific agonist ligand to increase apoptosis rate |
| 09/23/2003 | US6624189 Byrostatin analogues, synthetic methods and uses |
| 09/23/2003 | US6624188 Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects |
| 09/18/2003 | WO2003076374A1 PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE |
| 09/18/2003 | WO2003053915A3 Compounds for the treatment of inflammatory disorders |
| 09/18/2003 | US20030176620 Synthetic methods for polyphenols |
| 09/18/2003 | US20030176506 For therapy of leukemia or other forms of cancer or for treating disease conditions caused by apoptosis of cells |
| 09/18/2003 | US20030176494 Novel coumarin and chromene compounds and methods of preparation and use thereof for treating or preventing viral infections |
| 09/18/2003 | US20030176493 Having antineoplastic activity; antioxidant activity; and inhibit DNA topoisomerase II enzyme |
| 09/18/2003 | US20030176491 For therapy and prophylaxis of prostatitis or interstitial cystitis, inflammatory bowel disease, Crohn's disease, ulcerative proctitis, or colitis, prostatic hypertrophy, uterine leiomyomas, breast cancer, endometrial cancer |
| 09/18/2003 | US20030176485 Calcium receptor active compounds |
| 09/18/2003 | US20030176448 Mitochondria protecting agents for treating mitochondria associated diseases |
| 09/18/2003 | US20030176420 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists |
| 09/18/2003 | US20030176324 Derivatives of water insoluble drugs which exhibit good activity and water solubility |
| 09/17/2003 | EP1343778A2 Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists |
| 09/17/2003 | EP1343753A2 Antimicrobial agents |
| 09/17/2003 | EP1196411B1 Bradykinin b1 receptor antagonists |
| 09/17/2003 | CN1443182A Process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities |
| 09/17/2003 | CN1443181A Phenyl-substituted 5,6-dihydropyrone derivatives for use as pesticides and herbicides |
| 09/17/2003 | CN1442414A Preparation method of d-alpha tocopherol |
| 09/17/2003 | CN1442399A Method of converting inositol derivative in bitter buckwheat seed into its monomer and its extraction product |
| 09/17/2003 | CN1121379C Synthesis and use of retinene derivative having negative hormone and/or antagonist activities |
| 09/17/2003 | CN1121376C Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives and matrix metalloprotease inhibitors |
| 09/17/2003 | CN1121374C Novel trienoic retinoid compounds and method |
| 09/17/2003 | CN1121368C Diethers suitable for use in prepn. of zieglernatta catalysts |
| 09/16/2003 | US6620842 Chalcones |
| 09/16/2003 | US6620838 Anticarcinogenic, antimestasis, and antiarthritic agents; osteoporosis and endometriosis treatment |
| 09/16/2003 | US6620806 Estrogen agonist/antagonist to prevente myocardial infarction or stroke, maintaining or improving vascular reactivity, treat renal failure, peripheral arterial occlusive disease, coronary artery disease, or raynaud's phenomenon |
| 09/16/2003 | US6620546 Ionic composition comprising salt having conductivity of greater than 10-5 S.cm-1 between -30 and 150 degrees C; cation is proton, hydronium, hydroxonium, nitrosonium, ammonium or metal cation; anion is carbanion containing fluorine |
| 09/16/2003 | CA2235421C Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 09/16/2003 | CA2037575C N-(4-piperidinyl) (dihydrobenzofuran or dihydro-2h-benzopyran) carboxamide derivatives |
| 09/12/2003 | WO2003074509A1 Heterocycle-bearing onium salts |
| 09/12/2003 | WO2003074044A1 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 09/11/2003 | US20030171372 Antiviral methods and compounds |
| 09/11/2003 | US20030171352 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators |
| 09/11/2003 | US20030170842 Crystal proteins comprising proline substitutions; vapor diffusion; nuclear magnetic resonance; high resolution |
| 09/11/2003 | US20030170725 Modulation of polyketide synthase gene modules; anticancer agents, fungicide, bactericide |
| 09/11/2003 | US20030170332 Flavonoid extract |
| 09/11/2003 | US20030170292 Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof |
| 09/11/2003 | US20030168970 Luminescent element material and luminescent element comprising the same |
| 09/10/2003 | EP1341778A1 Klainetin and derivatives thereof, method for their production and the use of the same |
| 09/10/2003 | EP0925292B1 Processes and intermediates for preparing substituted chromanol derivatives |
| 09/10/2003 | CN1441796A Cyclic substituted aminomethyl compounds and medicaments containing said compounds |
| 09/10/2003 | CN1441794A Lipid-rich plague inhibitors |
| 09/10/2003 | CN1441792A Silent mark for oil product and detection method thereto |
| 09/10/2003 | CN1441771A Method for producing 3,3-diarylpropylamines |
| 09/10/2003 | CN1440969A Prepn process of high-purity mixed tocopherol |
| 09/10/2003 | CN1120839C Synthesis and application of 5,7-dihydroxy-4'-benzyloxyflaranone |
| 09/09/2003 | US6617465 Reacting an olefin with hydrogen peroxide in the presence of a titanium zeolite catalyst; regeneration of deactivated catalyst with hydrogen peroxide in presence of olefin while continuing epoxidation reaction |
| 09/09/2003 | US6617445 Asymmetric benzoxanthene dye for use as signaling tools in nucleotide sequence analysis |
| 09/09/2003 | US6617124 7-alkoxycoumarins as cytochrome p450 substrates |
| 09/04/2003 | US20030166950 Intermediates for use in the preparation of vitamin e |
| 09/04/2003 | US20030166711 A non-peptide and a non- nucleotide compound, culture product of penicillium sp. SPF-3059 |
| 09/04/2003 | US20030166708 Cyclic substituted aminomethyl compounds and medicaments comprising these compounds |
| 09/04/2003 | US20030166690 Use of compounds for decreasing activity of hormone-sensitive |
| 09/04/2003 | US20030166650 E.g., 3-(2-fluorophenyl)-N-(1-(3-morpholin-4-yl)phenyl)-propyl)acrylamide; disorders responsive to opening of KCNQ potassium channels; analgesics; migraine, bipolar disorders, anticonvulsants, antiepileptic, anxiolytic agents |
| 09/04/2003 | US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 09/04/2003 | US20030165444 Lipochroman-6 as no-synthase inhibitor and uses |
| 09/04/2003 | US20030164499 Fluorescent bis-coumarins for organic light-emitting devices |
| 09/03/2003 | EP1341403A1 Luminescent element material and luminescent element comprising the same |
| 09/03/2003 | EP1339798A2 Sulfonated diarylrhodamine dyes |
| 09/03/2003 | EP1339704A1 Method for continuously acylating chromanol ester derivatives |
| 09/03/2003 | EP1339670A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
| 09/03/2003 | CN1440399A Coumarin derivatives with COMT inhibiting activity |
| 09/03/2003 | CN1440383A PPARγ调制剂 PPARγ modulators |
| 09/03/2003 | CN1439367A Pratensein extraction and preparation thereof |
| 09/03/2003 | CN1120163C Soybean isoflavone and its prepn process with macroporous adsorption resin |
| 09/03/2003 | CN1120162C Novel benzopyran derivatives |
| 09/02/2003 | US6613917 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 09/02/2003 | US6613797 Xanthone analogs for treating infectious diseases and complexation of heme and porphyrins |
| 08/28/2003 | WO2003070718A1 MANUFACTURE OF (ALL-RAC)-α-TOCOPHEROL |
| 08/28/2003 | WO2003070713A1 Substituted aryl alkenoic acid heterocyclic amides possessing pungent taste |
| 08/28/2003 | WO2003070239A1 Benzylidene thiazolidinediones and their use as antimycotic agents |
| 08/28/2003 | WO2003070159A2 Novel coumarin and chromene compounds and methods of treating or preventing viral infections |
| 08/28/2003 | US20030162752 Sulphamate compounds for inhibiting oestrone sulphatase activity and aromatase activity; anticarcinogenic agents |
| 08/28/2003 | US20030162298 Complex is formed for detection of apoptosis/Alzheimer's plaques |
| 08/28/2003 | US20030162198 Medical diagnosis; complexing to Dna; calibration |
| 08/28/2003 | US20030162054 Red organic electroluminescent device |
| 08/28/2003 | US20030161903 Comprises solvent extract of compressed cake derived from defatted evening primrose seed wherein effective component contains polyphenol-essential elements such as ellagic acid, gallic acid, pentagalloylglucose and catechin |
| 08/28/2003 | US20030161900 Use of a dihydrochalcone-rich phenolic fraction in a cosmetic treatment |
| 08/28/2003 | US20030161860 Novel substituted aryl alkenoic acid heterocyclic amides |
| 08/27/2003 | EP1338270A2 Use of a dihydrochalcone-rich phenolic fraction in a cosmetic composition |
| 08/27/2003 | EP1140889B1 Compounds and methods for modulation of estrogen receptors |
| 08/27/2003 | EP0901469B1 Arylalkylpiperazine compounds as antioxidants |
| 08/27/2003 | CN1438977A Process for the preparation of nitroalkenes |
| 08/27/2003 | CN1438882A Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents |
| 08/27/2003 | CN1119340C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 08/26/2003 | US6610883 Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors |
| 08/26/2003 | US6610862 Preparation of warfarin sodium from warfarin sodium-2-propanol clathrate by solvent expulsion |
| 08/26/2003 | US6610742 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists |
| 08/26/2003 | US6610738 Treatment of Alzheimer's Disease by combining both acetylcholinesterase inhibitory activity and antioxidant activity (by virtue of their carbamoyl and flavonoid pharmacophores) |
| 08/26/2003 | US6610737 Non-psychotropic cannabinoids |
| 08/26/2003 | US6610733 Optically active chroman and thiochroman derivatives |
| 08/26/2003 | US6610732 For relieving or preventing constipation in a human constipated patient or preparing a bowel prior to preventative, diagnostic or surgical procedures |
| 08/26/2003 | US6610320 Mixture of cocoa plant extract and antichloesterol agent |
| 08/21/2003 | WO2002073214A3 Novel reagents for detecting cannabinoids |